1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Italy In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Italy In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Summary

GlobalData’s new report, "Italy In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the Italy In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for In Vitro Diagnostics market.
- Global corporate-level profiles of key companies operating within the Italy In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Italy In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 13
2.1 What Is This Report About? 13
2.2 In Vitro Diagnostics Market Segmentation 13
2.3 Definitions of Markets Covered in the Report 16
3 In Vitro Diagnostics Market, Italy 29
3.1 In Vitro Diagnostics Market, Italy, Revenue ($m), 2007-2021 29
3.2 In Vitro Diagnostics Market, Italy, Revenue Mix ($m), 2014 31
3.3 In Vitro Diagnostics Market, Italy, Category Contribution by Revenue ($m), 2014 32
3.4 In Vitro Diagnostics Market, Italy, Category Comparison by Revenue ($m), 2007-2021 33
3.5 In Vitro Diagnostics Market, Italy, Revenue ($m), 2007-2014 35
3.6 In Vitro Diagnostics Market, Italy, Revenue ($m), 2014-2021 37
3.7 In Vitro Diagnostics Market, Italy, Company Share by Revenue ($m), 2014 39
4 Clinical Chemistry Market, Italy 41
4.1 Clinical Chemistry Market, Italy, Revenue Mix ($m), 2014 41
4.2 Clinical Chemistry Market, Italy, Segment Contribution (%), 2014 42
4.3 Clinical Chemistry Market, Italy, Revenue ($m), 2007-2014 44
4.4 Clinical Chemistry Market, Italy, Revenue ($m), 2014-2021 46
4.4.1 Clinical Chemistry Analyzers Market, Italy, Revenue ($m), by Segment, 2007-2014 48
4.4.2 Therapeutic Drug Monitoring Market, Italy, Revenue ($m), by Segment, 2007-2014 50
4.4.3 Urine Analysis Market, Italy, Revenue ($m), by Segment, 2007-2014 52
4.4.4 Clinical Chemistry Analyzers Market, Italy, Revenue ($m), by Segment, 2014-2021 54
4.4.5 Therapeutic Drug Monitoring Market, Italy, Revenue ($m), by Segment, 2014-2021 56
4.4.6 Urine Analysis Market, Italy, Revenue ($m), by Segment, 2014-2021 58
4.5 Clinical Chemistry Market, Italy, Distribution Share by Revenue ($m), 2013-2014 60
4.6 Clinical Chemistry Market, Italy, Company Share by Revenue ($m), 2014 61
5 Genetic Testing Market, Italy 63
5.1 Genetic Testing Market, Italy, Revenue Mix ($m), 2014 63
5.2 Genetic Testing Market, Italy, Segment Contribution (%), 2014 64
5.3 Genetic Testing Market, Italy, Revenue ($m), 2007-2014 65
5.4 Genetic Testing Market, Italy, Revenue ($m), 2014-2021 67
5.5 Genetic Testing Market, Italy, Distribution Share by Revenue ($m), 2013-2014 69
5.6 Genetic Testing Market, Italy, Company Share by Revenue ($m), 2014 70
6 Haematology Market, Italy 72
6.1 Haematology Market, Italy, Revenue Mix ($m), 2014 72
6.2 Haematology Market, Italy, Segment Contribution (%), 2014 73
6.3 Haematology Market, Italy, Revenue ($m), 2007-2014 74
6.4 Haematology Market, Italy, Revenue ($m), 2014-2021 76
6.4.1 Haematology Cell Counters Market, Italy, Revenue ($m), by Segment, 2007-2014 78
6.4.2 Haematology Rapid Tests and POC Market, Italy, Revenue ($m), by Segment, 2007-2014 80
6.4.3 Haematology Reagents Market, Italy, Revenue ($m), by Segment, 2007-2014 82
6.4.4 Haemostasis Market, Italy, Revenue ($m), by Segment, 2007-2014 84
6.4.5 Immunohaematology Market, Italy, Revenue ($m), by Segment, 2007-2014 86
6.4.6 Haematology Cell Counters Market, Italy, Revenue ($m), by Segment, 2014-2021 88
6.4.7 Haematology Rapid Tests and POC Market, Italy, Revenue ($m), by Segment, 2014-2021 90
6.4.8 Haematology Reagents Market, Italy, Revenue ($m), by Segment, 2014-2021 92
6.4.9 Haemostasis Market, Italy, Revenue ($m), by Segment, 2014-2021 94
6.4.10 Immunohaematology Market, Italy, Revenue ($m), by Segment, 2014-2021 96
6.5 Haematology Market, Italy, Distribution Share by Revenue ($m), 2013-2014 98
6.6 Haematology Market, Italy, Company Share by Revenue ($m), 2014 99
7 Histology And Cytology Market, Italy 101
7.1 Histology And Cytology Market, Italy, Revenue Mix ($m), 2014 101
7.2 Histology And Cytology Market, Italy, Segment Contribution (%), 2014 102
7.3 Histology And Cytology Market, Italy, Revenue ($m), 2007-2014 103
7.4 Histology And Cytology Market, Italy, Revenue ($m), 2014-2021 105
7.5 Histology And Cytology Market, Italy, Distribution Share by Revenue ($m), 2013-2014 107
7.6 Histology And Cytology Market, Italy, Company Share by Revenue ($m), 2014 108
8 Immuno Chemistry Market, Italy 110
8.1 Immuno Chemistry Market, Italy, Revenue Mix ($m), 2014 110
8.2 Immuno Chemistry Market, Italy, Segment Contribution (%), 2014 111
8.3 Immuno Chemistry Market, Italy, Revenue ($m), 2007-2014 113
8.4 Immuno Chemistry Market, Italy, Revenue ($m), 2014-2021 115
8.4.1 Anemia Tests Market, Italy, Revenue ($m), by Segment, 2007-2014 117
8.4.2 Disease Specific Immunochemistry Market, Italy, Revenue ($m), by Segment, 2007-2014 119
8.4.3 Endocrinology Tests Market, Italy, Revenue ($m), by Segment, 2007-2014 121
8.4.4 IgE Allergy Blood Tests Market, Italy, Revenue ($m), by Segment, 2007-2014 123
8.4.5 Immunochemistry Analyzers Market, Italy, Revenue ($m), by Segment, 2007-2014 125
8.4.6 Immunochemistry Rapid Tests and POC Market, Italy, Revenue ($m), by Segment, 2007-2014 127
8.4.7 Vitamins Tests Market, Italy, Revenue ($m), by Segment, 2007-2014 129
8.4.8 Anemia Tests Market, Italy, Revenue ($m), by Segment, 2014-2021 131
8.4.9 Disease Specific Immunochemistry Market, Italy, Revenue ($m), by Segment, 2014-2021 133
8.4.10 Endocrinology Tests Market, Italy, Revenue ($m), by Segment, 2014-2021 135
8.4.11 IgE Allergy Blood Tests Market, Italy, Revenue ($m), by Segment, 2014-2021 137
8.4.12 Immunochemistry Analyzers Market, Italy, Revenue ($m), by Segment, 2014-2021 139
8.4.13 Immunochemistry Rapid Tests and POC Market, Italy, Revenue ($m), by Segment, 2014-2021 141
8.4.14 Vitamins Tests Market, Italy, Revenue ($m), by Segment, 2014-2021 143
8.5 Immuno Chemistry Market, Italy, Distribution Share by Revenue ($m), 2013-2014 145
8.6 Immuno Chemistry Market, Italy, Company Share by Revenue ($m), 2014 146
9 Infectious Diagnostics Market, Italy 148
9.1 Infectious Diagnostics Market, Italy, Revenue Mix ($m), 2014 148
9.2 Infectious Diagnostics Market, Italy, Segment Contribution (%), 2014 149
9.3 Infectious Diagnostics Market, Italy, Revenue ($m), 2007-2014 151
9.4 Infectious Diagnostics Market, Italy, Revenue ($m), 2014-2021 153
9.4.1 Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), by Segment, 2007-2014 155
9.4.2 Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), by Segment, 2014-2021 157
9.5 Infectious Diagnostics Market, Italy, Distribution Share by Revenue ($m), 2013-2014 159
9.6 Infectious Diagnostics Market, Italy, Company Share by Revenue ($m), 2014 160
10 Microbiology Culture Market, Italy 162
10.1 Microbiology Culture Market, Italy, Revenue Mix ($m), 2014 162
10.2 Microbiology Culture Market, Italy, Segment Contribution (%), 2014 163
10.3 Microbiology Culture Market, Italy, Revenue ($m), 2007-2014 165
10.4 Microbiology Culture Market, Italy, Revenue ($m), 2014-2021 167
10.4.1 Microbiology Analyzers Market, Italy, Revenue ($m), by Segment, 2007-2014 169
10.4.2 Microbiology Analyzers Market, Italy, Revenue ($m), by Segment, 2014-2021 171
10.5 Microbiology Culture Market, Italy, Distribution Share by Revenue ($m), 2013-2014 173
10.6 Microbiology Culture Market, Italy, Company Share by Revenue ($m), 2014 174
11 Overview of Key Companies in Italy, In Vitro Diagnostics Market 176
11.1 Siemens Healthcare 176
11.1.1 Company Overview 176
11.2 F. Hoffmann-La Roche Ltd. 176
11.2.1 Company Overview 176
11.3 Abbott Laboratories 176
11.3.1 Company Overview 176
11.4 Becton, Dickinson and Company 177
11.4.1 Company Overview 177
11.5 bioMerieux S.A. 177
11.5.1 Company Overview 177
11.6 Bio-Rad Laboratories, Inc. 177
11.6.1 Company Overview 177
11.7 Danaher Corporation 178
11.7.1 Company Overview 178
11.8 DiaSorin S.p.A 178
11.8.1 Company Overview 178
11.9 Horiba, Ltd. 178
11.9.1 Company Overview 178
11.10 Ortho-Clinical Diagnostics Inc. 178
11.10.1 Company Overview 178
11.11 Qiagen N.V. 179
11.11.1 Company Overview 179
11.12 Sysmex Corporation 179
11.12.1 Company Overview 179
11.13 Thermo Fisher Scientific Inc. 179
11.13.1 Company Overview 179
11.14 Alere Inc. 180
11.14.1 Company Overview 180
11.15 Mindray Medical International Limited 180
11.15.1 Company Overview 180
11.16 ELITech Group 180
11.16.1 Company Overview 180
12 In Vitro Diagnostics Market Pipeline Products 181
13 Financial Deals Landscape 187
13.1 Acquisition 187
13.1.1 Shanghai Kehua to Acquire Technogentics from Bouty Healthcare 187
13.1.2 Orphee Terminates Acquisition of Remaining 50% Stake in Diesse Diagnostica Senese for USD15 Million 189
13.2 Partnerships 190
13.2.1 Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 190
13.2.2 Seegene Enters into Co-Development Agreement with BD Life Sciences 191
13.2.3 MdxHealth Enters into Licensing Agreement with Erasmus MC 192
13.2.4 Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 193
13.2.5 Sigma-Aldrich Enters into Distribution Agreement with LGC 194
13.2.6 OvaGene Oncology Enters into Agreement with Etta Healthcare 195
13.2.7 InTouch Health Enters into Agreement with iSchemaView 196
13.2.8 Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 197
13.2.9 Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 198
13.2.10 Curetis Enters into Distribution Agreement with Arrow Diagnostics 199
13.2.11 DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 200
13.2.12 IncellDx Enters into Licensing Agreement with Claremont BioSolutions 201
13.2.13 Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 202
13.2.14 AngioDynamics Enters into Licensing Agreement with EmboMedics 203
13.2.15 Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 204
13.2.16 Biocartis Enters into Licensing and Development Agreement with Microbiome 205
13.2.17 Esperite Enters into Agreement with Premaitha Health 206
13.2.18 CBScientific Enters into Distribution Agreement with UTest 207
13.2.19 Norgine Enters into Distribution Agreement with Arc Medical Design for Endocuff Vision 208
13.2.20 GeneThera Enters into Co-Development Agreement with Hudson Robotics 209
13.2.21 Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 210
13.2.22 Ellen Enters into Distribution Agreement with Biosynex 211
13.2.23 KromaTiD Enters into Distribution Agreement with Tebu-bio 212
13.2.24 Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 213
13.2.25 Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 215
13.2.26 BioMerieux Enters into Licensing Agreement with Astute Medical 216
13.2.27 MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 217
13.2.28 NoemaLife Enters into Distribution Agreement with Horiba Medical 218
13.2.29 Clinical Genomics Enters into Licensing Agreement with CSIRO 219
13.2.30 BGI Diagnostics Enters into Technology Transfer Agreement with Bioscience Genomics 220
14 Recent Developments 221
14.1 Corporate Communications 221
14.1.1 Sep 09, 2015: Novocure to Present the Latest Data from the EF-14 Clinical Trial in Newly Diagnosed GBM at the 15th Interim Meeting of the World Federation of Neurosurgical Societies 221
14.2 Financial Announcements 222
14.2.1 Aug 25, 2015: EDAP Provides Formal Response to FDA Addressing All Concerns Raised in July 2015 Ablatherm HIFU Letter 222
14.2.2 Aug 25, 2015: High Throughput Single-Cell mRNA Sequencing Preparation Comes to the Fluidigm C1 System 223
14.2.3 Aug 25, 2015: SPR Therapeutics Awarded $1.6M NIH Grant to Study Pain Management Following Knee Replacement Surgery Using the Sprint PNS System 224
14.2.4 Aug 25, 2015: Xtant Medical Announces FDA Approval of OsteoSelect PLUS 227
14.2.5 Aug 25, 2015: Multi-center ALS Study Using the NeuRx Diaphragm Pacing System Shows Safety and Survival Post-Implant of 20.9 Months 228
14.2.6 Mar 03, 2015: LDR Holding Announces Global Distribution Agreement for SentioMMG Nerve Mapping System 231
14.2.7 Nov 14, 2014: The Board Of Directors Of Diasorin Approves The Consolidated Results For The Third Quarter Of 2014 Increase In Revenues And Profit Strong Free Cash Flow And Solid Net Financial Position 233
14.2.8 Nov 14, 2014: The Board Of Directors Of Diasorin Approves The Consolidated Results For The Third Quarter Of 2014: Increase In Revenues And Profit, Strong Free Cash Flow And Solid Net Financial Position 235
14.3 Government and Public Interest 236
14.3.1 Dec 18, 2014: Merit Medical Showcased Products for Lead Implantation at International Symposium on Clinical Pacing in Rome 236
14.4 Other Significant Developments 236
14.4.1 Jul 20, 2015: Diasorin And Beckman Coulter Sign A Distribution Partnership For Hepatitis And Hiv Tests In China 236
14.4.2 Jun 29, 2015: AbbVie's HOLKIRA PAK Now Reimbursed in Ontario 237
14.4.3 Apr 27, 2015: Linkage Biosciences Partners With Italian Distributor 239
14.5 Product News 239
14.5.1 Jul 01, 2015: Overcoming Challenges in Sequence Analysis of FFPE Tissue Due to Heterogeneity 239
14.6 Strategy And Business Planning 240
14.6.1 Jul 07, 2015: Shionogi Announces the Continued Expansion of their Operations in Europe with the Launch of Shionogi Italy 240
14.6.2 Mar 17, 2015: SIFI announces development in Mexico and appointment of new Country Manager 240
15 Appendix 241
15.1 Research Methodology 242
15.1.1 Coverage 242
15.1.2 Secondary Research 242
15.1.3 Primary Research 242
15.1.4 Company Share Analysis 243
15.1.5 Distribution Share Analysis 243
15.2 GlobalData Consulting 243
15.3 Contact Us 243
15.4 Disclaimer 244

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, Italy, Revenue ($m), USD Constant, 2007-2021 30
Table 2: In Vitro Diagnostics Market, Italy, Category Contribution by Revenue ($m), 2014 32
Table 3: In Vitro Diagnostics Market, Italy, Category Comparison by Revenue ($m), USD Constant, 2007-2021 34
Table 4: In Vitro Diagnostics Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 36
Table 5: In Vitro Diagnostics Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Table 6: In Vitro Diagnostics Market, Italy, Company Share by Revenue ($m), USD Constant, 2014 40
Table 7: Clinical Chemistry Market, Italy, Segment Contribution (%), 2014 43
Table 8: Clinical Chemistry Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 45
Table 9: Clinical Chemistry Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 47
Table 10: Clinical Chemistry Analyzers Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 49
Table 11: Therapeutic Drug Monitoring Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 51
Table 12: Urine Analysis Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 53
Table 13: Clinical Chemistry Analyzers Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Table 14: Therapeutic Drug Monitoring Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 57
Table 15: Urine Analysis Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 59
Table 16: Clinical Chemistry Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014 60
Table 17: Clinical Chemistry Market, Italy, Company Share by Revenue ($m), USD Constant, 2014 62
Table 18: Genetic Testing Market, Italy, Segment Contribution (%), 2014 64
Table 19: Genetic Testing Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 66
Table 20: Genetic Testing Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 68
Table 21: Genetic Testing Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014 69
Table 22: Genetic Testing Market, Italy, Company Share by Revenue ($m), USD Constant, 2014 71
Table 23: Haematology Market, Italy, Segment Contribution (%), 2014 73
Table 24: Haematology Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 75
Table 25: Haematology Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 77
Table 26: Haematology Cell Counters Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 79
Table 27: Haematology Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 81
Table 28: Haematology Reagents Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 83
Table 29: Haemostasis Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 85
Table 30: Immunohaematology Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 87
Table 31: Haematology Cell Counters Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 89
Table 32: Haematology Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 91
Table 33: Haematology Reagents Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Table 34: Haemostasis Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Table 35: Immunohaematology Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 97
Table 36: Haematology Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014 98
Table 37: Haematology Market, Italy, Company Share by Revenue ($m), USD Constant, 2014 100
Table 38: Histology And Cytology Market, Italy, Segment Contribution (%), 2014 102
Table 39: Histology And Cytology Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 104
Table 40: Histology And Cytology Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 106
Table 41: Histology And Cytology Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014 107
Table 42: Histology And Cytology Market, Italy, Company Share by Revenue ($m), USD Constant, 2014 109
Table 43: Immuno Chemistry Market, Italy, Segment Contribution (%), 2014 112
Table 44: Immuno Chemistry Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 114
Table 45: Immuno Chemistry Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 116
Table 46: Anemia Tests Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 118
Table 47: Disease Specific Immunochemistry Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 120
Table 48: Endocrinology Tests Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 122
Table 49: IgE Allergy Blood Tests Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 124
Table 50: Immunochemistry Analyzers Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 126
Table 51: Immunochemistry Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 128
Table 52: Vitamins Tests Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 130
Table 53: Anemia Tests Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 132
Table 54: Disease Specific Immunochemistry Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 134
Table 55: Endocrinology Tests Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 136
Table 56: IgE Allergy Blood Tests Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 138
Table 57: Immunochemistry Analyzers Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 140
Table 58: Immunochemistry Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 142
Table 59: Vitamins Tests Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 144
Table 60: Immuno Chemistry Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014 145
Table 61: Immuno Chemistry Market, Italy, Company Share by Revenue ($m), USD Constant, 2014 147
Table 62: Infectious Diagnostics Market, Italy, Segment Contribution (%), 2014 150
Table 63: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 152
Table 64: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 154
Table 65: Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 156
Table 66: Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 158
Table 67: Infectious Diagnostics Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014 159
Table 68: Infectious Diagnostics Market, Italy, Company Share by Revenue ($m), USD Constant, 2014 161
Table 69: Microbiology Culture Market, Italy, Segment Contribution (%), 2014 164
Table 70: Microbiology Culture Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 166
Table 71: Microbiology Culture Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 168
Table 72: Microbiology Analyzers Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 170
Table 73: Microbiology Analyzers Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 172
Table 74: Microbiology Culture Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014 173
Table 75: Microbiology Culture Market, Italy, Company Share by Revenue ($m), USD Constant, 2014 175
Table 76: In Vitro Diagnostics Market Pipeline Products 181
Table 77: Shanghai Kehua to Acquire Technogentics from Bouty Healthcare 187
Table 78: Orphee Terminates Acquisition of Remaining 50% Stake in Diesse Diagnostica Senese for USD15 Million 189
Table 79: Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 190
Table 80: Seegene Enters into Co-Development Agreement with BD Life Sciences 191
Table 81: MdxHealth Enters into Licensing Agreement with Erasmus MC 192
Table 82: Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 193
Table 83: Sigma-Aldrich Enters into Distribution Agreement with LGC 194
Table 84: OvaGene Oncology Enters into Agreement with Etta Healthcare 195
Table 85: InTouch Health Enters into Agreement with iSchemaView 196
Table 86: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 197
Table 87: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 198
Table 88: Curetis Enters into Distribution Agreement with Arrow Diagnostics 199
Table 89: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 200
Table 90: IncellDx Enters into Licensing Agreement with Claremont BioSolutions 201
Table 91: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 202
Table 92: AngioDynamics Enters into Licensing Agreement with EmboMedics 203
Table 93: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 204
Table 94: Biocartis Enters into Licensing and Development Agreement with Microbiome 205
Table 95: Esperite Enters into Agreement with Premaitha Health 206
Table 96: CBScientific Enters into Distribution Agreement with UTest 207
Table 97: Norgine Enters into Distribution Agreement with Arc Medical Design for Endocuff Vision 208
Table 98: GeneThera Enters into Co-Development Agreement with Hudson Robotics 209
Table 99: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 210
Table 100: Ellen Enters into Distribution Agreement with Biosynex 211
Table 101: KromaTiD Enters into Distribution Agreement with Tebu-bio 212
Table 102: Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 213
Table 103: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 215
Table 104: BioMerieux Enters into Licensing Agreement with Astute Medical 216
Table 105: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 217
Table 106: NoemaLife Enters into Distribution Agreement with Horiba Medical 218
Table 107: Clinical Genomics Enters into Licensing Agreement with CSIRO 219
Table 108: BGI Diagnostics Enters into Technology Transfer Agreement with Bioscience Genomics 220

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, Italy, Revenue ($m), USD Constant, 2007-2021 29
Figure 2: In Vitro Diagnostics Market, Italy, Revenue Mix ($m), 2014 31
Figure 3: In Vitro Diagnostics Market, Italy, Category Contribution (%), 2014 32
Figure 4: In Vitro Diagnostics Market, Italy, Category Comparison by Revenue ($m), USD Constant, 2007-2021 33
Figure 5: In Vitro Diagnostics Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 35
Figure 6: In Vitro Diagnostics Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 37
Figure 7: In Vitro Diagnostics Market, Italy, Company Share (%) 2014 39
Figure 8: Clinical Chemistry Market, Italy, Revenue Mix ($m), 2014 41
Figure 9: Clinical Chemistry Market, Italy, Segment Contribution (%), 2014 42
Figure 10: Clinical Chemistry Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 44
Figure 11: Clinical Chemistry Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 46
Figure 12: Clinical Chemistry Analyzers Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 48
Figure 13: Therapeutic Drug Monitoring Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 50
Figure 14: Urine Analysis Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 52
Figure 15: Clinical Chemistry Analyzers Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 54
Figure 16: Therapeutic Drug Monitoring Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Figure 17: Urine Analysis Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 58
Figure 18: Clinical Chemistry Market, Italy, Company Share (%) 2014 61
Figure 19: Genetic Testing Market, Italy, Revenue Mix ($m), 2014 63
Figure 20: Genetic Testing Market, Italy, Segment Contribution (%), 2014 64
Figure 21: Genetic Testing Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 65
Figure 22: Genetic Testing Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 67
Figure 23: Genetic Testing Market, Italy, Company Share (%) 2014 70
Figure 24: Haematology Market, Italy, Revenue Mix ($m), 2014 72
Figure 25: Haematology Market, Italy, Segment Contribution (%), 2014 73
Figure 26: Haematology Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 74
Figure 27: Haematology Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 76
Figure 28: Haematology Cell Counters Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 78
Figure 29: Haematology Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 80
Figure 30: Haematology Reagents Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 82
Figure 31: Haemostasis Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 84
Figure 32: Immunohaematology Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 86
Figure 33: Haematology Cell Counters Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 88
Figure 34: Haematology Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 90
Figure 35: Haematology Reagents Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 92
Figure 36: Haemostasis Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Figure 37: Immunohaematology Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 96
Figure 38: Haematology Market, Italy, Company Share (%) 2014 99
Figure 39: Histology And Cytology Market, Italy, Revenue Mix ($m), 2014 101
Figure 40: Histology And Cytology Market, Italy, Segment Contribution (%), 2014 102
Figure 41: Histology And Cytology Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 103
Figure 42: Histology And Cytology Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 105
Figure 43: Histology And Cytology Market, Italy, Company Share (%) 2014 108
Figure 44: Immuno Chemistry Market, Italy, Revenue Mix ($m), 2014 110
Figure 45: Immuno Chemistry Market, Italy, Segment Contribution (%), 2014 111
Figure 46: Immuno Chemistry Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 113
Figure 47: Immuno Chemistry Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 115
Figure 48: Anemia Tests Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 117
Figure 49: Disease Specific Immunochemistry Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 119
Figure 50: Endocrinology Tests Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 121
Figure 51: IgE Allergy Blood Tests Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 123
Figure 52: Immunochemistry Analyzers Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 125
Figure 53: Immunochemistry Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 127
Figure 54: Vitamins Tests Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 129
Figure 55: Anemia Tests Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 131
Figure 56: Disease Specific Immunochemistry Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 133
Figure 57: Endocrinology Tests Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 135
Figure 58: IgE Allergy Blood Tests Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 137
Figure 59: Immunochemistry Analyzers Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 139
Figure 60: Immunochemistry Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 141
Figure 61: Vitamins Tests Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 143
Figure 62: Immuno Chemistry Market, Italy, Company Share (%) 2014 146
Figure 63: Infectious Diagnostics Market, Italy, Revenue Mix ($m), 2014 148
Figure 64: Infectious Diagnostics Market, Italy, Segment Contribution (%), 2014 149
Figure 65: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 151
Figure 66: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 153
Figure 67: Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 155
Figure 68: Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 157
Figure 69: Infectious Diagnostics Market, Italy, Company Share (%) 2014 160
Figure 70: Microbiology Culture Market, Italy, Revenue Mix ($m), 2014 162
Figure 71: Microbiology Culture Market, Italy, Segment Contribution (%), 2014 163
Figure 72: Microbiology Culture Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 165
Figure 73: Microbiology Culture Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 167
Figure 74: Microbiology Analyzers Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 169
Figure 75: Microbiology Analyzers Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 171
Figure 76: Microbiology Culture Market, Italy, Company Share (%) 2014 174

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.